Evidence map›Paper›PMID 24062249›Full record

ArticleDiabetes2014

Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via central nervous system ghrelin receptors.

Kristy M Heppner, Carolin L Piechowski, Anne Müller, Nickki Ottaway, Stephanie Sisley, David L Smiley, Kirk M Habegger, Paul T Pfluger, Richard Dimarchi, Heike Biebermann and 3 more

Open access · greenAbstract read
In one paragraph

Article in Diabetes, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 3 syntheses or guidelines pooled it, 116 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Ghrelin regulating liver activity and its potential effects on liver fibrosis andFrontiers in cellular and infection microbiology · 2023
    Review
  13. Review
  14. Article
  15. The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Kristy M HeppnerDepartment of Medicine, Metabolic Diseases Institute, University of Cincinnati, Cincinnati, OH.
Carolin L Piechowski
Anne Müller
Nickki Ottaway
Stephanie Sisley
David L Smiley
Kirk M Habegger
Paul T Pfluger
Richard Dimarchi
Heike Biebermann
Matthias H Tschöp
Darleen A Sandoval
Diego Perez-Tilve
University of Cincinnati · USCharité - Universitätsmedizin Berlin · DEIndiana University Bloomington · USCincinnati Children's Hospital Medical Center · USTechnical University of Munich · DE

Funding

Neuroendocrine Regulation of Adipocyte MetabolismR01DK077975 · NIDDK · UNIVERSITY OF CINCINNATI · PI PEREZ-TILVE, DIEGO · 2009 to 2013
$1.7M
Development and Application of Ghrelin O-acyltransferase InhibitorsR24DK093434 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI COLE, PHILIP A · 2011 to 2011
$491k
NIDDK NIH HHS 5R01DK-077975NIDDK NIH HHS R01 DK077975NIDDK NIH HHS R24 DK093434NIDDK NIH HHS R24DK-093434-01
6 · The paper itself

Abstract

Growth hormone secretagogue receptors (GHSRs) in the central nervous system (CNS) mediate hyperphagia and adiposity induced by acyl ghrelin (AG). Evidence suggests that des-AG (dAG) has biological activity through GHSR-independent mechanisms. We combined in vitro and in vivo approaches to test possible GHSR-mediated biological activity of dAG. Both AG (100 nmol/L) and dAG (100 nmol/L) significantly increased inositol triphosphate formation in human embryonic kidney-293 cells transfected with human GHSR. As expected, intracerebroventricular infusion of AG in mice increased fat mass (FM), in comparison with the saline-infused controls. Intracerebroventricular dAG also increased FM at the highest dose tested (5 nmol/day). Chronic intracerebroventricular infusion of AG or dAG increased glucose-stimulated insulin secretion (GSIS). Subcutaneously infused AG regulated FM and GSIS in comparison with saline-infused control mice, whereas dAG failed to regulate these parameters even with doses that were efficacious when delivered intracerebroventricularly. Furthermore, intracerebroventricular dAG failed to regulate FM and induce hyperinsulinemia in GHSR-deficient (Ghsr(-/-)) mice. In addition, a hyperinsulinemic-euglycemic clamp suggests that intracerebroventricular dAG impairs glucose clearance without affecting endogenous glucose production. Together, these data demonstrate that dAG is an agonist of GHSR and regulates body adiposity and peripheral glucose metabolism through a CNS GHSR-dependent mechanism.

Indexed as

AdiposityAnimalsCentral Nervous SystemGhrelinGlucoseHEK293 CellsHumansInfusions, IntraventricularMiceReceptors, GhrelinGhrelinghrelin, des-n-octanoylGlucoseReceptors, Ghrelin

Identifiers

PMID24062249
PMCPMC3868046
OpenAlexW2142736927

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.